The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sch 1- Ultima Networks PLC

6 May 2005 13:20

AIM06 May 2005 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME: Ultima Networks PLC COMPANY ADDRESS: Akhter House, Perry Road, Harlow, Essex COMPANY POSTCODE: CM18 7PN COUNTRY OF INCORPORATION: England COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY: The principal activities of the Group are the development, licensing and support of professional software, the supply of telecoms products and services, the installation and distribution of energy saving products, property rentals and the provision of networking products and services. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares,nominal value and issue price to which it seeks admission and the number andtype to be held as treasury shares): £2,043,941.91 nominal share capitalcomprising 204,394,191 ordinary shares of 1p each. CAPITAL TO BE RAISED ON ADMISSION: Nil FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS: Humayun Akhter Mughal - Executive ChairmanRobert Jeffrey Piper - Finance Director and Company SecretaryPeter John Barron - Non-Executive DirectorPeter Young Thoms - Non-Executive Director PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS APERCENTAGE OF THE ISSUED SHARE CAPITAL STATING WHETHER BEFORE OR AFTERADMISSION: The following persons are interested in 3% or more of the capital ofUltima Networks PLC: Akhter Group plc (of which Mr. H. A Mughal is a director)and related parties (in which Mr. H. A Mughal has beneficial interests) 48.62%, NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE2, PARAGRAPH (G) OF THE AIM RULES: Khalid Malik, director of subsidiary company,C2 Communications Limited, has been paid £34,000 and is owed £7,500 in respectof consultancy fees, totalling £41,500. Khalid Malik can be contacted c/o C2Communications Limited, Akhter House, Perry Road, Harlow, Essex, CM18 7PN. ANTICIPATED ACCOUNTING REFERENCE DATE: 31 December EXPECTED ADMISSION DATE: 7 June 2005 NAME AND ADDRESS OF NOMINATED ADVISER: ARM Corporate Finance Limited, 12 Pepper Street, London E14 9RP NAME AND ADDRESS OF BROKER: ARM Corporate Finance Limited, 12 Pepper Street, London E14 9RP DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BEAVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THEAPPLICANT AND THE ADMISSION OF ITS SECURITIES: Not applicable.Transfer from the Official List DATE OF NOTIFICATION: 6 May 2005 NEW/ UPDATE (see note): New QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING: THE NAME OF THE AIM DESIGNATED MARKET UPON WHICH THE APPLICANT'S SECURITIES HAVE BEEN TRADED: UKLA Official List THE DATE FROM WHICH THE APPLICANT'S SECURITIES HAVE BEEN SO TRADED: 17 May 1984 CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHEREDTO ANY LEGAL AND REGULATORY REQUIREMENTS INVOLVED IN HAVING ITS SECURITIESTRADED UPON SUCH A MARKET: The Company confirms, having made due and carefulenquiry, that it has adhered to any to any legal and regulatory requirements inhaving its securities traded on the Official List of the UK Listing Authoritysave for a class 2 announcement delay dated 3 September 1998 which related tothe sale of shares in Pegasus PLC during April/May 1998. AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THEAPPLICANT HAS MADE PUBLIC OVER THE LAST TWO YEARS (IN CONSEQUENCE OF HAVING ITSSECURITIES SO TRADED) ARE AVAILABLE: http:// www.ultima-networks.co.uk DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASEOF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY: The Company intendsto pursue growth of its businesses both organically and by acquisition. A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THEAPPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FORWHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED: Annual report and accounts for theyear ended 31 December 2004 were approved on 19 April 2004 with a preliminaryannouncement published on 20 April 2004. The annual report and accounts for theyear ended 31 December 2004 are available from the company's web-site addresshttp://www.ultima-networks.co.uk A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THATTHE WORKING CAPITAL AVAILABLE TO IT OF ITS GROUP WILL BE INSUFFICIENT FOR ATLEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION: The Directors of the Companyhave no reason to believe that the working capital available to it will beinsufficient for at least twelve months from the date of its admission. DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES: Not applicable. A BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT'S SECURITIES:Transfers of the ordinary shares in the Company are settled through CREST and incertificated form. A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT'S SECURITIES:http://www.ultima-networks.co.uk INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOTCURRENTLY PUBLIC: see http:// www.ultima-networks.co.uk A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT'S LATEST ANNUAL REPORT ANDACCOUNTS WHICH MUST HAVE A FINANCIAL YEAR END NOT MORE THEN NINE MONTHS PRIOR TOADMISSION AND FULLY AUDITED INTERIM RESULTS WHERE APPLICABLE. THE ACCOUNTS MUSTBE PREPARED ACCORDING TO UK OR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS. http://www.ultima-networks.co.uk/accounts.html THE NUMBER OF EACH CLASS OF SECURITIES HELD IN TREASURY. None This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Apr 202410:59 amRNSPosting of Annual Report & Notice of AGM
26th Apr 20247:00 amRNSN4 Pharma Webinar on SRI Collaboration
25th Apr 20247:38 amRNSCollaboration Agreement with SRI International Inc
23rd Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSOral Delivery Update
4th Mar 20243:13 pmRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSin-vitro siRNA update
19th Jan 20247:00 amRNSPatent Grant
18th Jan 202410:15 amRNSHolding(s) in Company
16th Jan 20247:00 amRNSNanogenics Update
8th Jan 20244:24 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSAAV Viral Vector Update
18th Dec 20237:00 amRNSOral Delivery Update
7th Dec 202311:28 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSNuvec® R&D and Strategy Update
30th Nov 20239:00 amRNSN4 Pharma Launches New Interactive Investor Hub
31st Oct 20237:00 amRNSTotal Voting Rights
9th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 20238:15 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSInvestor Presentation
28th Sep 20237:00 amRNSAcquisition of Controlling Interest in Nanogenics
12th Sep 20237:00 amRNSInterim Results
25th Jul 20237:00 amRNSPatent Grant and Board Change
27th Jun 20237:00 amRNSGrant Award for Professor Chengzhong Yu
25th Apr 20237:00 amRNSsiRNA update
18th Apr 20237:00 amRNSsiRNA update
3rd Apr 20232:11 pmRNSResult of AGM
9th Mar 20237:00 amRNSPosting of Annual Report & Notice of AGM
9th Mar 20237:00 amRNSFinal Results
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20232:05 pmRNSSecond Price Monitoring Extn
17th Jan 20232:00 pmRNSPrice Monitoring Extension
17th Jan 202311:05 amRNSSecond Price Monitoring Extn
17th Jan 202311:00 amRNSPrice Monitoring Extension
17th Jan 20239:05 amRNSSecond Price Monitoring Extn
17th Jan 20239:00 amRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSOral application update
30th Nov 20225:28 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20222:49 pmRNSHolding(s) in Company
22nd Nov 202210:50 amRNSResult of Broker Offer and Total Voting Rights
18th Nov 20227:01 amRNSBroker Offer to raise a maximum of £1 million
18th Nov 20227:00 amRNSPlacing to raise £1million and Broker Offer
1st Nov 20227:00 amRNSPatent filing update
4th Oct 20227:00 amRNSDouble siRNA Testing Update
29th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSOperational Update
15th Jul 20227:00 amRNSWork Programme Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.